KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Receivables (2016 - 2025)

Medpace Holdings' Change in Receivables history spans 11 years, with the latest figure at $29.1 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 290.49% year-over-year to $29.1 million; the TTM value through Dec 2025 reached $106.2 million, up 4837.51%, while the annual FY2025 figure was $106.2 million, 4837.51% up from the prior year.
  • Change in Receivables reached $29.1 million in Q4 2025 per MEDP's latest filing, up from -$4.9 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $79.9 million in Q2 2025 to a low of -$19.1 million in Q1 2024.
  • Average Change in Receivables over 5 years is $12.2 million, with a median of $6.7 million recorded in 2022.
  • Peak YoY movement for Change in Receivables: surged 7103.12% in 2022, then plummeted 540.06% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$64000.0 in 2021, then soared by 7103.12% to $4.5 million in 2022, then skyrocketed by 100.09% to $9.0 million in 2023, then plummeted by 270.32% to -$15.3 million in 2024, then surged by 290.49% to $29.1 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Change in Receivables are $29.1 million (Q4 2025), -$4.9 million (Q3 2025), and $79.9 million (Q2 2025).